Mirtazapine

Spezifikationen

85650-52-8CAS-Nummer

288-060-6EG-Nummer

5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaeneIUPAC-Name

C17H19N3Chemische Formel

265.35 g/molMolekulargewicht

mirtazapine; 85650-52-8; Remeron; Mepirzepine; 6-Azamianserin; Remergon; Zispin; Promyrtil; Remergil; Rexer; Avanza; Norset; Remeron SolTab; Mirtazapina; ORG 3770; Mirtazapinum; 2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; Org-3770; Mirataz; Mirtazapin; Mirtazapine anhydrous; Mepirzapine; DTXSID0023325; 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine; A051Q2099Q; Org3770; Pyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-; CHEBI:6950; DTXCID503325; 5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene; Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-; 5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8(13),9,11,15,17-hexaene; Remeronsoltab; 6 Azamianserin; 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c]benzazepine; 2-methyl-1,2,3,4,10,14b-hexahydropyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine; 5-methyl-2,5,19-triazatetracyclo(13.4.0.0^(2,7).0^(8,13))nonadeca-1(19),8(13),9,11,15,17-hexaene; 5-methyl-2,5,19-triazatetracyclo(13.4.0.02,7.08,13)nonadeca-1(15),8,10,12,16,18-hexaene; RefChem:55652; N06AX11; 61337-67-5; Mirtazepine; Mepirzapin; Mirtazipine; Mirtazapinum [INN-Latin]; Mirtazapina [INN-Spanish]; 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; MFCD00865427; 2-methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepine; CHEMBL654; Mirtazapine (Remeron, Avanza); (S)-Org3770;(S)-6-Azamianserin; NCGC00025346-02; (14bR)-2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; Azamianserin; Mirtazapine [USAN:BAN:INN]; Smilon; 2-methyl-1,2,3,4,9,13b-hexahydro-2,4a,5-triaza-tribenzo[a,c,e]cycloheptene; Diosmetin 3',7-Bis(2,3,4-tri-O-acetyl-D-glucuronic Acid Methyl Ester); 159355-60-9; SMR000466347; Remeron (TN); SR-01000597530; EINECS 288-060-6; Mirtazapine CRS; UNII-A051Q2099Q; (R)-Org3770;(R)-6-Azamianserin; 6-Aza-mianserin; 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c](2)benzazepine; Mirtazapine [USAN:USP:INN:BAN]; Reflex (TN); (1)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine; ME-2040; Mirtazapine (Standard); MIRTAZAPINE [MI]; MIRTAZAPINE [INN]; MIRTAZAPINE [JAN]; MIRTAZAPINE [USAN]; MIRTAZAPINE [VANDF]; SCHEMBL35408; MIRTAZAPINE [USP-RS]; MIRTAZAPINE [WHO-DD]; MLS000759460; MLS001076676; MLS001424294; MLS006011449; orb322593; Mirtazapine (JAN/USP/INN); GTPL7241; orb1310902; orb3141190; Mirtazapine - Bio-X trade mark; MIRTAZAPINE [GREEN BOOK]; SCHEMBL29484433; HY-B0352R; MIRTAZAPINE, (+/-)-; Mirtazapine, >=98% (HPLC); Mirtazapine, 1mg/ml in Methanol; MIRTAZAPINE [ORANGE BOOK]; HMS2052H03; HMS2233K03; HMS3268F21; HMS3370B05; HMS3374J01; HMS3394H03; HMS3413C11; HMS3657M13; HMS3677C11; HMS3713P13; HMS3884O18; HMS5080H15; MIRTAZAPINE [EP MONOGRAPH]; MIRTAZAPINE [USP MONOGRAPH]; PS11 - Mirtazapine/Normirtazapine; HY-B0352; Mirtazapine 1.0 mg/ml in Methanol; MSK10500; Tox21_110965; BBL009962; BDBM50115644; EBC-08263; PDSP1_001529; PDSP2_001513; s2016; STK711107; AKOS005530681; CCG-101154; CCG-220556; DB00370; FM26014; KS-1086; NC00404; NCGC00025346-01; NCGC00025346-08; NCGC00025346-12; AC-15480; BM164672; SY002095; CAS-61337-67-5; M2151; NS00009441; SW197784-4; T0137; EN300-49851; C07570; D00563; AB00698265_08; L001294; Q421930; SR-01000597530-1; SR-01000597530-4; BRD-A64977602-001-01-9; BRD-A64977602-001-04-3; BRD-A64977602-001-13-4; BRD-A64977602-001-14-2; BRD-A64977602-001-15-9; Z905065772; Mirtazapine, European Pharmacopoeia (EP) Reference Standard; Mirtazapine, United States Pharmacopeia (USP) Reference Standard; (+/-)-12-Methyl-1,2,3,4,9,13b-hexahydro-2,4a,5-triaza-tribenzo[a,c,e]cycloheptene; 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]-benzazepine; Mirtazapine for system suitability, European Pharmacopoeia (EP) Reference Standard; 5-methyl-2,5,19-triazatetracyclo[13.4.0.0?,?.0?,??]nonadeca-1(15),8,10,12,16,18-hexaene; 5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8,10,12,15,17-hexaene; Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (.+/-.)-; Mirtazapine Coated; Mirtazapina hemihidratoSynonyme